Nchi: Marekani
Lugha: Kiingereza
Chanzo: NLM (National Library of Medicine)
AZELASTINE HYDROCHLORIDE (UNII: 0L591QR10I) (AZELASTINE - UNII:ZQI909440X)
Sandoz Inc
INTRAOCULAR
PRESCRIPTION DRUG
Azelastine Hydrochloride Ophthalmic Solution, 0.05% is indicated for the treatment of itching of the eye associated with allergic conjunctivitis. Azelastine Hydrochloride Ophthalmic Solution, 0.05% is contraindicated in persons with known or suspected hypersensitivity to any of its components.
Azelastine Hydrochloride Ophthalmic Solution, 0.05% is supplied sterile in a natural LDPE plastic bottle with a natural LDPE dropper tip and a white polypropylene cap as follows: Storage Azelastine Hydrochloride Ophthalmic Solution, 0.05% 6 mL container: STORE UPRIGHT between 2° and 25°C (36° and 77°F). Rx Only Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc. Princeton, NJ 08540 Printed in USA Rev. August 2021 300049853-0821
Abbreviated New Drug Application
AZELASTINE HYDROCHLORIDE- AZELASTINE HYDROCHLORIDE SOLUTION/ DROPS SANDOZ INC ---------- AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION, 0.05% DESCRIPTION Azelastine Hydrochloride Ophthalmic Solution, 0.05% is a sterile ophthalmic solution containing azelastine hydrochloride, a relatively selective H -receptor antagonist for topical administration to the eyes. Azelastine hydrochloride is a white crystalline powder with a molecular weight of 418.37. Azelastine hydrochloride is sparingly soluble in water, methanol and propylene glycol, and slightly soluble in ethanol, octanol, and glycerine. Azelastine hydrochloride is a racemic mixture with a melting point of 225°C. The chemical name for azelastine hydrochloride is (±)-1-(2H)-phthalazinone,4-[(4- chlorophenyl)methyl]-2- (hexahydro-1-methyl-1H-azepin-4-yl)-, monohydrochloride and is represented by the following chemical structure: Empirical chemical structure: C H ClN O•HCl Each mL of Azelastine Hydrochloride Ophthalmic Solution, 0.05% contains: ACTIVE: 0.5 mg azelastine hydrochloride, equivalent to 0.457 mg of azelastine base; PRESERVATIVE: 0.125 mg benzalkonium chloride; INACTIVES: disodium edetate dihydrate, hypromellose, sorbitol solution, sodium hydroxide and water for injection. It has a pH of approximately 5.0 to 6.5 and an osmolarity of approximately 271 to 312 mOsmol/L. CLINICAL PHARMACOLOGY Azelastine hydrochloride is a relatively selective histamine H antagonist and an inhibitor of the release of histamine and other mediators from cells (e.g. mast cells) involved in the allergic response. Based on _in-vitro_ studies using human cell lines, inhibition of other mediators involved in allergic reactions (e.g. leukotrienes and PAF) has been demonstrated with azelastine hydrochloride. Decreased chemotaxis and activation of eosinophils has also been demonstrated. 1 22 24 3 1 PHARMACOKINETICS AND METABOLISM: Absorption of azelastine following ocular administration was relatively low. A study in symptomatic patients receiving one drop of Azelastine Hydrochlorid Soma hati kamili